https://orcid.org/0000-0002-5373-8987
References
- Cejka C, Kubinova S, Cejkova J. Trehalose in ophthalmology. Histol Histopathol. 2019;34:611–618. doi:10.14670/HH-18-082
- Takeuchi K, Nakazawa M, Ebina Y. Effects of trehalose on VEGF-stimulated angiogenesis and myofibroblast proliferation: implications for glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2011;52:6987–6993. doi:10.1167/iovs.11-7478
- Nakamura T, Sekiyama E, Takaoka M, et al. The use of trehalose-treated freeze-dried amniotic membrane for ocular surface reconstruction. Biomaterials. 2008;29:3729–3737. doi:10.1016/j.biomaterials.2008.05.023
- Takeuchi K, Nakazawa M, Ebina Y, et al. Inhibitory effects of trehalose on fibroblast proliferation and implications for ocular surgery. Exp Eye Res. 2010;91:567–577. doi:10.1016/j.exer.2010.07.002
- Cantor LB, Mantravadi A, WuDunn D, Swamynathan K, Cortes A. Morphologic classification of filtering blebs after glaucoma filtration surgery: the Indiana bleb appearance grading scale. J Glaucoma. 2003;12:266–271. doi:10.1097/00061198-200306000-00015
- Caretti L, La Gloria Valerio A, Piermarocchi R, et al. Efficacy of carbomer sodium hyaluronate trehalose vs hyaluronic acid to improve tear film instability and ocular surface discomfort after cataract surgery. Clin Ophthalmol. 2019;13:1157–1163. doi:10.2147/OPTH.S208256
- Orobia AJM, Pascual PC, Bescós JC, et al. Effects of 3% trehalose as an adjuvant treatment after LASIK. Clin Ophthalmol. 2017;11:347–353. doi:10.2147/OPTH.S125203
- Pinto-Bonilla JC, Del Olmo-Jimeno A, Llovet-Osuna F, Hernandez-Galilea E. A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome. Ther Clin Risk Manag. 2015;11:595–603. doi:10.2147/TCRM.S77091
- Chiambaretta F, Doan S, Labetoulle M, et al. HA-trehalose Study Group. A randomized, controlled study of the efficacy and safety of a new eye drop formulation for moderate to severe dry eye syndrome. Eur J Ophthalmol. 2017;27:1–9. doi:10.5301/ejo.5000836
- Ji H, Zhu Y, Zhang Y, et al. Dry eye disease in patients with functioning filtering blebs after trabeculectomy. PLoS One. 2016;11:e0152696. doi:10.1371/journal.pone.0152696
- Lee S-Y, Wong TT, Chua J, et al. Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity. Eye (Lond). 2013;27:1142–1150. doi:10.1038/eye.2013.144
- Lam J, Wong TT, Tong L. Ocular surface disease in posttrabeculectomy/mitomycin C patients. Clin Ophthalmol. 2015;9:187–191. doi:10.2147/OPTH.S70721
- Zhang X, Vadoothker S, Munir WM, Saeedi O. Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens. 2019;45:11–18. doi:10.1097/ICL.0000000000000544
- Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008;17:350–355. doi:10.1097/IJG.0b013e31815c5f4f
- Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29:618–621. doi:10.1097/ICO.0b013e3181c325b2
- Yılmaz SG, Değirmenci C, Palamar M, Yağcı A. Evaluation of filtering bleb function after trabeculectomy with mitomycin c using biomicroscopy, anterior segment optical coherence tomography and in vivo confocal microscopy. Turk J Ophthalmol. 2015;45(4):132–137. doi:10.4274/tjo.29052